Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R de Wit

Showing results (81-90 of 147) with videos related to

Pageof 15
Sort By:
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 28, 2010
Improving guideline adherence in the treatment of atrial fibrillation by implementing an integrated chronic care programJ L M Hendriks, R Nieuwlaat, H J M Vrijhoef, et al.
British Journal of Cancer|June 1, 1995
Thermal enhancement of both tumour necrosis factor alpha-induced systemic toxicity and tumour cure in ratsJ van der Zee, G J van den Aardweg, G C van Rhoon, et al.
Journal of Internal Medicine|June 1, 1991
Interleukin-6 concentrations in the serum of patients with AIDS-associated Kaposi's sarcoma during treatment with interferon-alphaR de Wit, M H Raasveld, R J ten Berge, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
EORTC phase II study of daily oral linomide in metastatic renal cell carcinoma patients with good prognostic factorsR de Wit, A Pawinsky, G Stoter, et al.
Journal of Pain and Symptom Management|July 26, 2000
A pain monitoring program for nurses: effects on nurses' pain knowledge and attitudeM E de Rond, R de Wit, F S van Dam, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
An EORTC phase II study of the efficacy and safety of linomide in the treatment of advanced renal cell carcinomaA Pawinski, A T van Oosterom, R de Wit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2003
Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapyR de Wit, J Herrstedt, B Rapoport, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A dose-escalation study of recombinant interferon-alpha in patients with a metastatic carcinoid tumourC H Veenhof, R de Wit, B G Taal, et al.
British Journal of Cancer|March 20, 2003
External validity of a prediction rule for residual mass histology in testicular cancer: an evaluation for good prognosis patientsY Vergouwe, E W Steyerberg, R de Wit, et al.
British Journal of Cancer|September 22, 1998
Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of CancerR de Wit, G Stoter, D T Sleijfer, et al.
Pageof 15

Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 28, 2010
Improving guideline adherence in the treatment of atrial fibrillation by implementing an integrated chronic care programJ L M Hendriks, R Nieuwlaat, H J M Vrijhoef, et al.
British Journal of Cancer|June 1, 1995
Thermal enhancement of both tumour necrosis factor alpha-induced systemic toxicity and tumour cure in ratsJ van der Zee, G J van den Aardweg, G C van Rhoon, et al.
Journal of Internal Medicine|June 1, 1991
Interleukin-6 concentrations in the serum of patients with AIDS-associated Kaposi's sarcoma during treatment with interferon-alphaR de Wit, M H Raasveld, R J ten Berge, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
EORTC phase II study of daily oral linomide in metastatic renal cell carcinoma patients with good prognostic factorsR de Wit, A Pawinsky, G Stoter, et al.
Journal of Pain and Symptom Management|July 26, 2000
A pain monitoring program for nurses: effects on nurses' pain knowledge and attitudeM E de Rond, R de Wit, F S van Dam, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
An EORTC phase II study of the efficacy and safety of linomide in the treatment of advanced renal cell carcinomaA Pawinski, A T van Oosterom, R de Wit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2003
Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapyR de Wit, J Herrstedt, B Rapoport, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A dose-escalation study of recombinant interferon-alpha in patients with a metastatic carcinoid tumourC H Veenhof, R de Wit, B G Taal, et al.
British Journal of Cancer|March 20, 2003
External validity of a prediction rule for residual mass histology in testicular cancer: an evaluation for good prognosis patientsY Vergouwe, E W Steyerberg, R de Wit, et al.
British Journal of Cancer|September 22, 1998
Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of CancerR de Wit, G Stoter, D T Sleijfer, et al.
Pageof 15